The Republican-led hearing – convened to scrutinize Fauci’s management of the pandemic and the origins of COVID-19 – was the ...

With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that offers pipeline-in-a-product ...

Indian Institute of Technology Madras has released the revised GATE Biotechnology Syllabus 2027. Compared to the previous ...

Why successful technology transfer depends on early planning, process understanding and close collaboration from development ...

A key theme emerging from FDA complete response letters since 2018 is that data system validation is lacking in the ...

In a sudden leadership shift, Legend Biotech announced that its CEO Ying Huang, Ph.D., resigned on Friday, with no permanent ...

Ying Huang, Ph.D., steps down as Chief Executive Officer and member of the Board of Directors; will remain as an advisor through August to ...

A new initiative from the Trump administration called Operation Trailblazer aims to reduce the time it takes for new drugs to ...

Effective 12:01 a.m. ET on July 22, 2026, a 25% ad valorem Section 301 tariff will apply to substantially all goods originating in Brazil under Sections 301(b) and 304(a) of the Trade Act of 1974.

(NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related ...

Elevara Medicines Appoints Biotech Veteran as CEO Founder and former CEO of Nasdaq listed IO Biotech, Dr Mai-Britt Zocca ...

Marketed for longevity and wellness benefits, the unproven therapies are sold through a grey market online. Compounding pharmacies say they should be able to make them legally to meet demand.